Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy
Clinical trial NCT00908349 · COMPLETED
Trial details
- NCT number
- NCT00908349
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2011-11-01
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.